Kirkland & Ellis is advising the consortium consisting of EQT and Luxinva (a wholly owned subsidiary of the Abu Dhabi Investment Authority) who have partnered with a subsidiary of the Public Sector Pension Investment Board and other renowned institutional investors on the CHF 10.200 billion exclusive negotiations to acquire Nestlé Skin Health, a leading global skincare company. Nestlé Skin Health provides science-based solutions to meet the specific skin health needs of healthcare professionals, patients and consumers. It offers a range of leading medical and consumer brands through three complementary business units in prescription, aesthetics and consumer care. Headquartered in Lausanne, Switzerland, Nestlé Skin Health employs more than 5,000 people across 40 countries. The proposed transaction is subject to employee consultations and customary regulatory approvals.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.